Pernix Therapeutics Holdings, Inc.(NASDAQ : PTX)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading PTX News...
Health Technology » Pharmaceuticals Other
|SHPG||Shire PLC Sponsored ADR||-7.91%||166.03||9.9%||$682.82m|
|VRX||Valeant Pharmaceuticals International, Inc.||-8.85%||20.28||7.1%||$590.12m|
|PRGO||Perrigo Co. Plc||-4.44%||90.97||4.0%||$246.55m|
|ENDP||Endo International Plc||-6.25%||14.85||4.1%||$131.38m|
|JAZZ||Jazz Pharmaceuticals Plc||-4.90%||137.90||2.7%||$122.88m|
|ICPT||Intercept Pharmaceuticals, Inc.||-7.35%||142.92||13.8%||$89.19m|
|HZNP||Horizon Pharma plc||-6.82%||16.25||9.7%||$64.47m|
|UTHR||United Therapeutics Corporation||-3.01%||102.11||19.5%||$61.35m|
|GWPH||GW Pharmaceuticals PLC Sponsored ADR||-6.54%||83.31||12.2%||$37.71m|
Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. The firm distributes its products under the following brands: Treximet, Silenor, Zohydro ER with BeadTek, and Khedezla. The company was founded on March 9, 2010 and is headquartered in The Woodlands, TX.